Uncategorized

ADA: Lilly bests Novo again, takes GLP-1 pill Foundayo to FDA for diabetes approval

Published

3 days ago

on

Newly approved weight loss pill Foundayo reduced blood sugar more than Novo Nordisk’s semaglutide and other comparators in multiple Phase 3 type 2 diabetes trials. Eli Lilly will seek approval in this indication.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version